NYSE · Healthcare
DAVITA INC. (DVA)
As-reported financials and recent SEC filings for DAVITA INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$13.64B
Net income
$746.8M
Net margin
5.5%
Diluted EPS
$9.84
ROE
-199.8%
P/E (TTM)
20.9×
Market cap
$13.93B
Debt / equity
-27.2×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| Gross profit | — | — | — | — | — |
| Operating income | $2.04B | $2.09B | $1.60B | $1.34B | $1.80B |
| Net income | $746.8M | $936.3M | $691.5M | $560.4M | $978.5M |
| Diluted EPS | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →11-K2026-06-17
View on EDGAR →1442026-06-16
View on EDGAR →1442026-06-15
View on EDGAR →1442026-06-15
View on EDGAR →1442026-06-15
View on EDGAR →8-K2026-06-08
View on EDGAR →Go deeper on DVA
Search DAVITA INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.